Nivolumab in patients with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis Meeting Abstract


Authors: Brahmer, J. R.; Horn, L.; Gandhi, L.; Spigel, D. R.; Antonia, S. J.; Rizvi, N. A.; Powderly, J. D.; Heist, R. S.; Carvajal, R. D.; Jackman, D. M.; Sequist, L. V.; Smith, D. C.; Leming, P. D.; Topalian, S. L.; Hodi, S.; Snzol, M.; Harbison, C. T.; Kollia, G. D.; Gupta, A.; Gettinger, S. N.
Abstract Title: Nivolumab in patients with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis
Meeting Title: COSA's 41st Annual Scientific Meeting
Journal Title: Asia-Pacific Journal of Clinical Oncology
Volume: 10
Issue: Suppl.8
Meeting Dates: 2014 Dec 2-4
Meeting Location: Melbourne, Australia
ISSN: 1743-7555
Publisher: Wiley Blackwell  
Date Published: 2014-12-01
Start Page: 157
Language: English
ACCESSION: WOS:000345350900247
PROVIDER: wos
PUBMED: 25409571
DOI: 10.1111/ajco.12305
Notes: Meeting Abstract: 299 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard D Carvajal
    148 Carvajal
  2. Naiyer A Rizvi
    166 Rizvi